Overcoming challenges of treating inflammatory bowel disease in pregnancy (Q30251775)

13 June 2017

title

Overcoming challenges of treating inflammatory bowel disease in pregnancy (English)

1 reference

inflammatory bowel diseases

13 June 2017

main subject

1 reference

Jill K J Gaidos

1

1 reference

13 June 2017

Sunanda V Kane

series ordinal

2

1 reference

13 June 2017

language of work or name

1 reference

16 March 2016

1 reference

Expert Review of Clinical Immunology

13 June 2017

published in

1 reference

13 June 2017

volume

12

1 reference

13 June 2017

issue

8

1 reference

13 June 2017

page(s)

871-878

1 reference

Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions

13 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Ulcerative colitis and pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Systematic review: fertility in non-surgically treated inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Association between maternal inflammatory bowel disease and adverse perinatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Crohn's disease is a risk factor for preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

First trimester exposure to corticosteroids and oral clefts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Teratogen update: azathioprine and 6-mercaptopurine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Early pregnancy azathioprine use and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Optimizing the use of thiopurines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Use of Immunomodulators and Biologics Before, During, and After Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

European evidenced-based consensus on reproduction in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

Immunosuppressive drugs and fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

A prospective study of the safety of lower gastrointestinal endoscopy during pregnancy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/1744666X.2016.1166958

10.1586/1744666X.2016.1166958

21 January 2018

Identifiers

DOI

1 reference

13 June 2017

1 reference